XML 61 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity
12 Months Ended
Dec. 31, 2013
Stockholders' Equity [Abstract]  
Stockholders' Equity

Note 8---Stockholders' Equity

 

 Convertible Preferred Stock

 

As of December 31, 2013, there were no outstanding shares of convertible preferred stock.  Our Board of Directors and our stockholders have authorized 1,000,000 shares of convertible preferred stock that are available for issuance.

 

Common Stock

 

As of December 31, 2013, we had reserved 211,631 common shares for future issuance upon the exercise of stock options.

 

Activity in our stock option plans is as follows (in thousands, except per share amount and years): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2013

 

 

 

 

 

 

Weighted-

 

Weighted-

 

 

 

 

 

 

 

 

 

Average

 

Average

 

 

 

 

 

 

 

 

 

Exercise

 

Remaining

 

Aggregate

 

 

 

 

Options

 

Price

 

Contractual

 

Intrinsic

 

 

 

 

(000's)

 

Per Share

 

Term (Years)

 

Value

 

Outstanding at beginning of period

 

 

366 

 

$

14.88 

 

 

 

 

 

 

 

Granted

 

 

375 

 

$

9.49 

 

 

 

 

 

 

 

Exercised

 

 

(11)

 

$

9.23 

 

 

 

 

$

11 

 

Forfeited

 

 

(48)

 

$

9.06 

 

 

 

 

 

 

 

Expired

 

 

(18)

 

$

24.39 

 

 

 

 

 

 

 

Outstanding at end of period

 

 

664 

 

$

12.08 

 

 

8.37 

 

$

150 

 

Options exercisable at end of period

 

 

209 

 

$

17.02 

 

 

6.47 

 

$

42 

 

Options vested and expected to vest at end of period

 

 

533 

 

$

12.66 

 

 

8.11 

 

$

120 

 

 

The weighted-average fair market value per share of options granted under our stock option plans during fiscal 2013 and 2012 was $6.02 and $10.37, respectively.

 

We granted 6,809 shares of restricted stock to the non-employee members of our Board of Directors in June 2013, and recorded a stock-based compensation expense of $65,000.  We granted 5,798 shares of restricted stock to the non-employee members of our Board of Directors in 2012, and recorded a stock-based compensation expense of $50,000. The restricted stock will vest over a one-year period measured from the date of the annual meeting of stockholders with one quarter of the shares included in such Director Grant vesting on each of the dates that are three months, six months, nine months and twelve months from the annual meeting, so long as each board member continues to serve as a member of our board of directors on such vesting date.

 

 

 

As of December 31, 2013, total unrecognized compensation cost related to unvested stock options was $2,394,000, which is expected to be recognized over the remaining weighted-average vesting periods of 1.64 years. During the year ended December 31, 2013 and 2012, we have received cash of $484,000 and $2,167,000, respectively from the exercise of stock options and employee stock purchases.